Bayer, J&J Fight Calls to Unify Blood-Thinner Death Suits
This article is for subscribers only.
Bayer AG and Johnson & Johnson are fighting calls to consolidate lawsuits over a blood-thinning drug blamed for causing some patients to bleed to death, a move that would make it easier for plaintiffs to prepare their cases.
Patients who took Xarelto accuse the drugmakers of downplaying the medicine’s bleeding risks and asked that the cases be gathered before U.S District Judge David Herndon in East St. Louis, Illinois, for pretrial information exchanges, according to court filings. Consumers contend 65 deaths have been linked to bleeding caused by the drug, which has no antidote, according to court filings.